{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:40:31Z","timestamp":1762954831916,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.joms.2009.01.011","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T04:15:24Z","timestamp":1239768924000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Bisphosphonates\u2014What the Dentist Needs to Know: Practical Considerations"],"prefix":"10.1016","volume":"67","author":[{"given":"John E.","family":"Fantasia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2009.01.011_bib1","first-page":"795","article-title":"Osteonecrosis of the maxilla: An unusual complication of prolonged bisphosphonate therapy: A case report","volume":"22","author":"Mehrotra","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.joms.2009.01.011_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/154405910708601101","article-title":"Osteonecrosis of the jaws and bisphosphonate therapy","volume":"86","author":"Ruggiero","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2009.01.011_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2009.01.011_bib5","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.joms.2009.01.011_bib6","doi-asserted-by":"crossref","unstructured":"Scheper MA, Baros A, Chaisuparat R, et al: Effect of zoledronic acid on oral fibroblasts and epithelial cells: A potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol Epub 2008 Nov 27","DOI":"10.1182\/blood.V112.11.5131.5131"},{"key":"10.1016\/j.joms.2009.01.011_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1754-4505.2006.tb01503.x","article-title":"Bisphosphonate induced osteochemonecrosis of the jaws: An ounce of prevention may be worth a pound of cure","volume":"26","author":"Hellstein","year":"2006","journal-title":"Spec Care Dentistry"},{"key":"10.1016\/j.joms.2009.01.011_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2009.01.011_bib10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bone.2007.01.016","article-title":"A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density","volume":"40","author":"Saag","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.01.011_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.2000.18.6.1378","article-title":"American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2009.01.011_bib12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/009127002762491316","article-title":"Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases","volume":"42","author":"Chen","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.joms.2009.01.011_bib13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2009.01.011_bib14","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/1078-0432.CCR-08-0666","article-title":"Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss","volume":"14","author":"Berenson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2009.01.011_bib15","first-page":"1351","article-title":"Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours","volume":"15","author":"Santini","year":"2006","journal-title":"Oncol Reports"},{"key":"10.1016\/j.joms.2009.01.011_bib16","first-page":"707","article-title":"Childhood chronic recurrent multifocal osteomyelitis: Pamidronate therapy decreases pain and improves vertebral shape","volume":"35","author":"Gleeson","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joms.2009.01.011_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/1357714031000114165","article-title":"Bisphosphonate treatment of benign multifocal and unifocal osteolytic tumours of bone","volume":"7","author":"Gibbons","year":"2003","journal-title":"Sarcoma"},{"key":"10.1016\/j.joms.2009.01.011_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14219\/jada.archive.2008.0016","article-title":"Bisphosphonate use and the risk of adverse jaw outcomes: A medical claims study of 714,217 people","volume":"139","author":"Cartos","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2009.01.011_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","article-title":"Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial","volume":"139","author":"Grbic","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2009.01.011_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3949\/ccjm.75a.08014","article-title":"Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk?","volume":"75","author":"Carey","year":"2008","journal-title":"Cleveland Clinic J Med"},{"key":"10.1016\/j.joms.2009.01.011_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.joms.2009.01.011_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: Bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joms.2009.01.011_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2009.01.011_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2141.2005.05833.x","article-title":"Bisphosphonate-associated osteonecrosis of the auditory canal","volume":"132","author":"Polizzotto","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.joms.2009.01.011_bib26","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib28","first-page":"439","article-title":"Current and future applications of bone turnover markers","volume":"49","author":"Christgau","year":"2003","journal-title":"Clin Lab"},{"key":"10.1016\/j.joms.2009.01.011_bib29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1359\/jbmr.080312","article-title":"Effects of intravenous zoledronate on bone turnover and BMD persists for at least 24 months","volume":"23","author":"Bolland","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2009.01.011_bib30","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/sj.bjc.6604390","article-title":"Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases","volume":"98","author":"Generali","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.joms.2009.01.011_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tripleo.2008.01.033","article-title":"Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws","volume":"106","author":"Lehrer","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2009.01.011_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1359\/JBMR.041212","article-title":"Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone","volume":"20","author":"Alexandersen","year":"2005","journal-title":"J Bone Miner Res"},{"year":"2008","series-title":"Oral bisphosphonates and jaw osteonecrosis: Preliminary results of a single institution, retrospective analysis","author":"Chan","key":"10.1016\/j.joms.2009.01.011_bib33"},{"key":"10.1016\/j.joms.2009.01.011_bib34","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.14219\/jada.archive.2008.0110","article-title":"Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: An advisor statement from the American Dental Association Council on Scientific Affairs","volume":"139","author":"Edwards","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2009.01.011_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2009.01.011_bib36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2009.01.011_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5694\/j.1326-5377.2005.tb06970.x","article-title":"Bisphosphonates and osteonecrosis: Analogy to phossy jaw","volume":"183","author":"Donaghue","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.joms.2009.01.011_bib38","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.joms.2007.11.006","article-title":"Uncovering the cause of \u201cphossy jaw\u201d circa 1858 to 1906: Oral and maxillofacial surgery closed case file\u2014Case closed","volume":"66","author":"Marx","year":"2008","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239109001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239109001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:27:17Z","timestamp":1759508837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239109001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0278239109001189"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2009.01.011","relation":{},"ISSN":["0278-2391"],"issn-type":[{"type":"print","value":"0278-2391"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates\u2014What the Dentist Needs to Know: Practical Considerations","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2009.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}